Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2005
06/02/2005US20050118181 Use of antibody against GBV-C E2 to treat human immunodeficiency virus (HIV); vaccines
06/02/2005US20050118177 Method for the improvement of neuronal regeneration
06/02/2005US20050118176 Inhibiting binding of interleukin-4 (IL-4) to an IL-4 Receptor; suppressing an IL-4-dependent immune or inflammatory response in a mammal
06/02/2005US20050118175 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
06/02/2005US20050118174 Polypeptide variants with altered effector function
06/02/2005US20050118173 Compositions and methods to accelerate hematologic recovery
06/02/2005US20050118172 Humanized antibody CAMPATH-1H administered with steroid (hydrocortisone)
06/02/2005US20050118171 Treatment of rheumatoid arthritis with CD99 antagonists
06/02/2005US20050118170 Use of discoidin domain receptor 1 (ddr1) and agents that affect the ddr1/collagen pathway
06/02/2005US20050118169 For inflammatory diseases; rheumatoid arthritis; hybridoma cell lines
06/02/2005US20050118168 Administering a compound which binds to a C-type lectin on the surface of a dendritic cell, with the proviso that the C-type lectin is not the DEC-205 receptor
06/02/2005US20050118167 Parenteral pharmaceutical composition containing humanized monoclonal antibody fragment and stabilizing method thereof
06/02/2005US20050118166 Inhibiting activation by CD40 ligand (CD40L) of cells bearing CD40 on the cell surface, other than B cells, by contacting with an agent that inhibits the interaction between CD40L and the cells; treating autoimmune diseases
06/02/2005US20050118165 useful for imaging such tumors; scintigraphic detection, diagnosis, prognosis, monitoring and therapy of Met-bearing tumors
06/02/2005US20050118164 Targeted ligands
06/02/2005US20050118163 Antibody-containing solution pharmaceuticals
06/02/2005US20050118162 Treatment of micro-organism infection
06/02/2005US20050118161 Hevein-binding monoclonal antibodies
06/02/2005US20050118151 Drug screening; proteins that can be used as targets for the treatment of diabetes
06/02/2005US20050118149 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
06/02/2005CA2747871A1 Compositions and methods for the treatment of tumor of hematopoietic origin
06/02/2005CA2554635A1 Compounds, compositions containing such compounds and methods of treatment of autoimmune diseases using such compounds
06/02/2005CA2546873A1 Surface-located campylobacter jejuni polypeptides
06/02/2005CA2546840A1 Immunization against chlamydia infection
06/02/2005CA2546836A1 Immunization against chlamydia infection
06/02/2005CA2546794A1 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients
06/02/2005CA2546566A1 Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia
06/02/2005CA2546406A1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
06/02/2005CA2546355A1 Novel atypical pneumonia-causing virus
06/02/2005CA2546285A1 Compositions and methods for the treatment of tumor of hematopoietic origin
06/02/2005CA2546237A1 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
06/02/2005CA2545893A1 Anti-hydroxylase antibodies and uses thereof
06/02/2005CA2545806A1 Methods of modulating immunity
06/02/2005CA2545697A1 Self-cleaving ribozymes and uses thereof
06/02/2005CA2542215A1 Screening assays and methods of tumor treatment
06/02/2005CA2528549A1 Use of epha4 and modulator of epha4 for diagnosis, treatment and prevention of cancer
06/01/2005EP1536234A2 Soluble CTLA4 mutant molecules and uses thereof
06/01/2005EP1536012A1 Human antihuman interleukin-6 antibody and fragment of the antibody
06/01/2005EP1536010A1 Preventives/remedies for cancer
06/01/2005EP1536008A1 2’,5’-OLIGOADENYLATE PHOSPHODIESTERASE
06/01/2005EP1536006A1 Cancer antigens and utilization thereof
06/01/2005EP1536004A1 Method of promoting homologous recombination of somatic cells and method of constructing specific antibody
06/01/2005EP1535930A1 Antibody specific to central tetra-protein
06/01/2005EP1535627A1 Recombinant bcg vaccine
06/01/2005EP1535046A2 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays
06/01/2005EP1535045A2 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays
06/01/2005EP1535044A2 Selecting therapeutic human monoclonal antibodies from disease-specific libraries
06/01/2005EP1534834A2 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
06/01/2005EP1534830A1 In vitro peptide expression libraray
06/01/2005EP1534827A1 Method for generating monoclonal antibodies
06/01/2005EP1534754A2 Bi-specific antigen-binding compositions and related methods
06/01/2005EP1534753A2 Antibody peg positional isomers, compositions comprising same, and use thereof
06/01/2005EP1534752A2 Antibodies that specifically bind to chemokine beta-4
06/01/2005EP1534750A2 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor
06/01/2005EP1534749A2 Variant integrin polypeptides and uses thereof
06/01/2005EP1534748A2 Fusion proteins and methods of producing same
06/01/2005EP1534747A2 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications
06/01/2005EP1534746A2 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins
06/01/2005EP1534736A2 Nogo receptor antagonists
06/01/2005EP1534730A2 Modified transferin-antibody fusion proteins
06/01/2005EP1534404A1 Use of a clathrate modifier to promote passage of proteins during nanofiltration
06/01/2005EP1534337A2 Ptk7 protein involvement in carcinoma
06/01/2005EP1534336A2 Antibodies that immunospecifically bind to trail receptors
06/01/2005EP1534335A2 Fcgammariib-specific antibodies and methods of use thereof
06/01/2005EP1534333A1 A method of immunomodulation
06/01/2005EP1534332A2 Antibodies and uses thereof
06/01/2005EP1534331A2 Membrane associated tumor endothelium markers
06/01/2005EP1534327A2 Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
06/01/2005EP1534324A2 Tumor specific oligosaccharide epitopes and use thereof
06/01/2005EP1534319A2 Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease
06/01/2005EP1534317A2 N-terminally truncated galectin-3 and antibodies for treating cancer
06/01/2005EP1534310A2 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
06/01/2005EP1534306A2 Defensins: use as antiviral agents
06/01/2005EP1534284A2 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
06/01/2005EP1534066A2 Alpha(1,3)-galactosyltransferase null cells, methods of selecting and alpha(1,3)-galactosyltransferase null swine produced therefrom
06/01/2005EP1483397A4 Oligomeric molecules and uses thereof
06/01/2005EP1404362A4 Signal-1/signal-2 bifunctional peptide inhibitors
06/01/2005EP1339747B1 Membrane fusion proteins derived from reovirus
06/01/2005EP1171160B1 Method and means for treating post-polio syndrome
06/01/2005EP1157041B1 Antibodies for cancer therapy and diagnosis
06/01/2005EP1042460B1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof
06/01/2005EP0906433B1 Protein tyrosine phosphatases of hematopoietic cells
06/01/2005EP0804559B1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria
06/01/2005EP0656941B1 Methods for producing members of specific binding pairs
06/01/2005CN1622995A Receptor nucleic acids and polypeptides
06/01/2005CN1622958A Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
06/01/2005CN1621417A Antibody against SARS-CoV IgY and its preparing method
06/01/2005CN1621416A Method for detecting antigen for severe acute respiratory syndrome (SARS) virus
06/01/2005CN1621415A Immunoglobulin antibody against SARS-CoV and its preparing method
06/01/2005CN1621091A Intestine targeted formulation of PEGylated rotavirus and its synthesizing method
06/01/2005CN1204253C Neisseria lactoferrin binding protein
06/01/2005CN1204146C Method for preparing alpha-fetoglobulin transspecific factor
05/2005
05/31/2005US6900302 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
05/31/2005US6900293 Monoclonal antibodies directed against the microtubule-associated protein tau
05/31/2005US6900288 Comprises membrane glycoproteins for diagnosis, prevention and treatment of nervous system and cell proliferative disorders
05/31/2005US6900056 Chemically defined medium for cultured mammalian cells
05/31/2005US6900054 Propagating preferential oligodendrocytes and/or astrocytes using embryonic neural cell adhesion molecule (E-NCAM) differentiated stem cells for treating neurological or neurodegenerative disease
05/31/2005US6900052 Method of culturing cells
05/31/2005US6900043 Phosphatases which activate map kinase pathways
05/31/2005US6900032 Human PTTG polypeptide and method for producing it
1 ... 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 ... 1494